Selected Drugs Clear All
MultiCheck Results
- 1
Interaction
Monitor/Modify Tx |
||
|
NovoLog
(insulin aspart) + Soliqua 100/33
(insulin glargine/ lixisenatide) |
||
Monitor/Modify Txinsulin + lixisenatide monitor glucose; consider dose adjustment of one or both drugs: combo may incr. risk of hypoglycemia (additive effects) |
||
Additional Considerations |
||
|
lixisenatide
in Soliqua 100/33
|
||
|
caution advised with oral drugs, especially narrow therapeutic index; lixisenatide delays gastric emptying, may alter absorption of concomitant oral drugs |
||